John Ackerman's most recent trade in Guardian Pharmacy Services Inc. - Ordinary Shares - Class A was a trade of 1,413,939 Class A Common Stock done . Disclosure was reported to the exchange on March 28, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Guardian Pharmacy Services Inc (Class A) | John Ackerman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2026 | 1,413,939 | 2,449,867 | - | - | Class A Common Stock | |
| Guardian Pharmacy Services Inc (Class A) | John Ackerman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2026 | 1,413,939 | 1,413,939 | - | - | Class B Common Stock | |
| Guardian Pharmacy Services Inc (Class A) | John Ackerman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2026 | 471,057 | 816,180 | - | - | Class A Common Stock | |
| Guardian Pharmacy Services Inc (Class A) | John Ackerman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2026 | 471,057 | 471,057 | - | - | Class B Common Stock | |
| Guardian Pharmacy Services Inc (Class A) | John Ackerman | Director | Sale of securities on an exchange or to another person at price $ 29.68 per share. | 20 Mar 2026 | 827,636 | 1,035,928 | - | 29.7 | 24,566,306 | Class A Common Stock |
| Guardian Pharmacy Services Inc (Class A) | John Ackerman | Director | Sale of securities on an exchange or to another person at price $ 29.68 per share. | 20 Mar 2026 | 275,728 | 345,123 | - | 29.7 | 8,184,296 | Class A Common Stock |
| Guardian Pharmacy Services Inc (Class A) | John Ackerman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Sep 2025 | 1,413,940 | 2,827,878 | - | - | Class B Common Stock | |
| Guardian Pharmacy Services Inc (Class A) | John Ackerman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Sep 2025 | 1,413,940 | 1,863,564 | - | - | Class A Common Stock | |
| Guardian Pharmacy Services Inc (Class A) | John Ackerman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Sep 2025 | 471,057 | 942,114 | - | - | Class B Common Stock | |
| Guardian Pharmacy Services Inc (Class A) | John Ackerman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Sep 2025 | 471,057 | 620,851 | - | - | Class A Common Stock | |
| Guardian Pharmacy Services Inc (Class A) | John Ackerman | Director | Sale of securities on an exchange or to another person at price $ 20.16 per share. | 27 May 2025 | 813,318 | 600,622 | - | 20.2 | 16,396,491 | Class A Common Stock |
| Guardian Pharmacy Services Inc (Class A) | John Ackerman | Director | Sale of securities on an exchange or to another person at price $ 20.16 per share. | 27 May 2025 | 270,958 | 200,099 | - | 20.2 | 5,462,513 | Class A Common Stock |
| Guardian Pharmacy Services Inc (Class A) | John Ackerman | Director | Sale of securities on an exchange or to another person at price $ 20.16 per share. | 27 May 2025 | 150,998 | 449,624 | - | 20.2 | 3,044,120 | Class A Common Stock |
| Guardian Pharmacy Services Inc (Class A) | John Ackerman | Director | Sale of securities on an exchange or to another person at price $ 20.16 per share. | 27 May 2025 | 50,305 | 149,794 | - | 20.2 | 1,014,149 | Class A Common Stock |
| Guardian Pharmacy Services Inc (Class A) | John Ackerman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 1,413,940 | 4,241,818 | - | - | Class B Common Stock | |
| Guardian Pharmacy Services Inc (Class A) | John Ackerman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 1,413,940 | 1,413,940 | - | - | Class A Common Stock | |
| Guardian Pharmacy Services Inc (Class A) | John Ackerman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 471,057 | 471,057 | - | - | Class A Common Stock | |
| Guardian Pharmacy Services Inc (Class A) | John Ackerman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 471,057 | 1,413,171 | - | - | Class B Common Stock | |
| Guardian Pharmacy Services Inc (Class A) | John Ackerman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Sep 2024 | 5,655,758 | 5,655,758 | - | - | Class B Common Stock | |
| Guardian Pharmacy Services Inc (Class A) | John Ackerman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Sep 2024 | 1,884,228 | 1,884,228 | - | - | Class B Common Stock |